User contributions
- 06:08, 26 December 2018 (diff | hist) . . (+28) . . ADPGK-AS1 (→Characteristics) (current)
- 06:04, 26 December 2018 (diff | hist) . . (+28) . . LINC01567 (→Regulation)
- 06:03, 26 December 2018 (diff | hist) . . (+84) . . FZD10-AS1
- 06:02, 26 December 2018 (diff | hist) . . (+28) . . LINC02595 (→Regulation) (current)
- 06:01, 26 December 2018 (diff | hist) . . (+54) . . LINC00514 (current)
- 06:00, 26 December 2018 (diff | hist) . . (+54) . . LINC01561
- 05:58, 26 December 2018 (diff | hist) . . (+54) . . TSPOAP1-AS1
- 05:57, 26 December 2018 (diff | hist) . . (+54) . . LINC00958 (→Annotated Information) (current)
- 05:54, 26 December 2018 (diff | hist) . . (+54) . . HPYR1 (→Annotated Information)
- 05:49, 26 December 2018 (diff | hist) . . (+28) . . CFAP58-DT (→Regulation)
- 05:48, 26 December 2018 (diff | hist) . . (+28) . . HOXB-AS1 (→Regulation) (current)
- 05:47, 26 December 2018 (diff | hist) . . (+28) . . ZFPM2-AS1 (→Regulation)
- 05:46, 26 December 2018 (diff | hist) . . (+28) . . LINC00554 (→Regulation)
- 05:45, 26 December 2018 (diff | hist) . . (-8) . . LINC00554 (→Characteristics)
- 05:44, 26 December 2018 (diff | hist) . . (-9) . . THUMPD3-AS1 (→Characteristics)
- 05:44, 26 December 2018 (diff | hist) . . (+28) . . LINC00092 (→Regulation)
- 05:42, 26 December 2018 (diff | hist) . . (-8) . . TTN-AS1 (→Characteristics) (current)
- 05:41, 26 December 2018 (diff | hist) . . (-8) . . DICER1-AS1 (→Characteristics)
- 05:40, 26 December 2018 (diff | hist) . . (+28) . . SNHG29 (→Characteristics)
- 05:37, 26 December 2018 (diff | hist) . . (0) . . IATPR (→Expression)
- 05:36, 26 December 2018 (diff | hist) . . (0) . . N File:Iatpr.jpg (current)
- 05:35, 26 December 2018 (diff | hist) . . (+4,173) . . N IATPR (Created page with "''IATPR'' is a long non-coding RNA and could be a potential biomarker in the prognosis of breast cancer. ==Annotated Information== ===Name=== ''IATPR'': ITGB1 adjacent tumo...")
- 04:44, 26 December 2018 (diff | hist) . . (+104) . . THORLNC (→Function)
- 04:42, 26 December 2018 (diff | hist) . . (0) . . N File:Thor.jpg (current)
- 03:48, 26 December 2018 (diff | hist) . . (+5,998) . . N THORLNC (Created page with "''THOR'' is a conserved testis lncRNA involved in multiple human carcinomas. ==Annotated Information== ===Name=== ''THORLNC'': testis associated oncogenic lncRNA (HGNC nome...")
- 03:09, 26 December 2018 (diff | hist) . . (+22) . . CPNE8-AS1 (→References)
- 03:06, 26 December 2018 (diff | hist) . . (+3,651) . . N CPNE8-AS1 (Created page with "LncRNA ''CPNE8-AS1'' is a potent biomarker for cervical cancer (CC) progression. ==Annotated Information== ===Name=== ''CPNE8-AS1'': CPNE8 antisense RNA 1 (HGNC nomenclature...")
- 02:31, 26 December 2018 (diff | hist) . . (+4,604) . . N FAM230A (Created page with "==Annotated Information== ===Name=== ''FAM230A'': family with sequence similarity 230 member A (HGNC nomenclature). ===Characteristics=== ''FAM230A'' (NCBI ID 653203 and UCSC...")
- 06:09, 25 December 2018 (diff | hist) . . (+3,906) . . N CFAP58-DT (Created page with "lncRNA ''CFAP58-DT'' orchestrates signal transduction for interferon (IFN) production and illustrates the essential role of lncRNAs in virus elimination. ==Annotated Informat...")
- 06:49, 24 December 2018 (diff | hist) . . (+3,582) . . N HOXB-AS1 (Created page with "Mouse counterpart of lncRNA ''HOXB-AS1'', ''Hoxb3os'' results in hyperactivation of mTORC1 and enhanced mitochondrial respiration. ==Annotated Information== ===Name=== ''HOXB...")
- 02:53, 24 December 2018 (diff | hist) . . (+96) . . ZFPM2-AS1 (→Function)
- 02:51, 24 December 2018 (diff | hist) . . (+60) . . N File:MIF.jpg (Schematic of gastric cancer progression <ref name="ref2" />.) (current)
- 02:32, 24 December 2018 (diff | hist) . . (+5,024) . . N ZFPM2-AS1 (Created page with "Novel lncRNA, ''ZFPM2-AS1'' has a critical role in gastric carcinogenesis. ==Annotated Information== ===Name=== ''ZFPM2-AS1'': ZFPM2 antisense RNA 1 (HGNC nomenclature). ==...")
- 07:47, 21 December 2018 (diff | hist) . . (+93) . . LINC00554
- 07:43, 21 December 2018 (diff | hist) . . (+5,747) . . N LINC00554 (Created page with "''LINC00554''is involved in a significant signal cascade which can be targetted for eliminating liver tumor-initiating cells (TICs). It is involved in self-renewal of TICs thr...")
- 05:21, 21 December 2018 (diff | hist) . . (+3,611) . . N THUMPD3-AS1 (Created page with "Neuron death is stimulated by ''THUMPD3-AS1'' in stroke via promoting ''PTEN'' expression. ==Annotated Information== ===Name=== ''THUMPD3-AS1'': THUMPD3 antisense RNA 1 (HGNC...")
- 03:07, 21 December 2018 (diff | hist) . . (+20) . . LINC00092
- 03:00, 21 December 2018 (diff | hist) . . (0) . . LINC00092 (→Expression)
- 02:57, 21 December 2018 (diff | hist) . . (+5,075) . . N LINC00092 (Created page with "''LINC00092'' is correlated with aggressiveness of ovarian cancer in vivo and in vitro and clinical outcome of ovarian cancer patients, interacted with 6-phosphofructo-2-kinas...")
- 09:00, 20 December 2018 (diff | hist) . . (0) . . TTN-AS1
- 08:58, 20 December 2018 (diff | hist) . . (+18) . . TTN-AS1
- 08:57, 20 December 2018 (diff | hist) . . (+19) . . TTN-AS1 (→Characteristics)
- 08:57, 20 December 2018 (diff | hist) . . (+4) . . TTN-AS1 (→Function)
- 08:56, 20 December 2018 (diff | hist) . . (-33) . . TTN-AS1 (→Expression)
- 08:55, 20 December 2018 (diff | hist) . . (+4,885) . . N TTN-AS1 (Created page with "''TTN-AS1''/''miR133b''''/FSCN1'' regulatory axis provides potential targets for anti-Esophageal Squamous Cell Carcinoma (ESCC) therapies. ==Annotated Information== ===Name==...")
- 07:54, 20 December 2018 (diff | hist) . . (+1) . . DICER1-AS1 (→Diseases)
- 07:53, 20 December 2018 (diff | hist) . . (+4) . . DICER1-AS1 (→Diseases)
- 07:52, 20 December 2018 (diff | hist) . . (+1) . . DICER1-AS1 (→Regulation)
- 07:52, 20 December 2018 (diff | hist) . . (+2,754) . . N DICER1-AS1 (Created page with "''DICER1-AS1'' has a role in proliferation, invasion and autophagy of osteosarcoma cells. ==Annotated Information== ===Name=== ''DICER1-AS1'': DICER1 antisense RNA 1 (HGNC...")
- 07:08, 20 December 2018 (diff | hist) . . (+3,291) . . N SNHG17 (Created page with "''SNHG17'' has a role in colorectal cancer (CRC) progression, depicting ''SNHG17'' as a potential therapeutic target for CRC patients. ==Annotated Information== ===Name=== ''...") (current)
- 08:46, 18 December 2018 (diff | hist) . . (+7) . . SNHG29
- 08:45, 18 December 2018 (diff | hist) . . (+3,944) . . N SNHG29 (Created page with "''SNHG29'' acts as a potential molecular biomarker to predict the prognosis in acute myeloid leukemia (AML) patients. This long non-coding RNA has a role in the pathological p...")
- 07:27, 18 December 2018 (diff | hist) . . (+1) . . RAB11B-AS1 (→Expression) (current)
- 07:27, 18 December 2018 (diff | hist) . . (+3,637) . . N RAB11B-AS1 (Created page with "RAB11B antisense RNA (''RAB11B-AS1'') is a long non-coding RNA which is markedly down-regulated in human osteosarcoma (OS) and associated with OS metastasis and poor prognosis...")
- 06:24, 18 December 2018 (diff | hist) . . (+2) . . ADPGK-AS1 (→Expression)
- 06:23, 18 December 2018 (diff | hist) . . (+5) . . ADPGK-AS1 (→Annotated Information)
- 06:22, 18 December 2018 (diff | hist) . . (-3) . . ADPGK-AS1
- 06:21, 18 December 2018 (diff | hist) . . (+4,519) . . N ADPGK-AS1 (Created page with "''ADPGK-AS1'' is involved in pancreatic cancer (PC, strongly promotes tumorigenesis via downregulating miR-205-5p expression and induces the epithelial-mesenchymal transition...")
- 05:57, 18 December 2018 (diff | hist) . . (-3) . . LINC00514 (→References)
- 05:56, 18 December 2018 (diff | hist) . . (-3) . . LINC00174 (→References)
- 05:55, 18 December 2018 (diff | hist) . . (-3) . . TSPOAP1-AS1 (→References)
- 05:53, 18 December 2018 (diff | hist) . . (-3) . . SSTR5-AS1 (→References) (current)
- 05:52, 18 December 2018 (diff | hist) . . (-2) . . SH3PXD2A-AS1 (→References) (current)
- 05:51, 18 December 2018 (diff | hist) . . (-6) . . LINC00958 (→References)
- 05:50, 18 December 2018 (diff | hist) . . (-3) . . HPYR1 (→References)
- 05:49, 18 December 2018 (diff | hist) . . (+1) . . FZD10-AS1 (→References)
- 05:48, 18 December 2018 (diff | hist) . . (+134) . . FZD10-AS1 (→References)
- 05:47, 18 December 2018 (diff | hist) . . (+238) . . LINC01567
- 05:44, 18 December 2018 (diff | hist) . . (+257) . . LINC02595
- 05:42, 18 December 2018 (diff | hist) . . (+233) . . LINC01561
- 03:13, 18 December 2018 (diff | hist) . . (+1) . . LINC01567
- 03:13, 18 December 2018 (diff | hist) . . (+4,966) . . N LINC01567 (Created page with "''LINC01567'', is a long non-coding RNA with the ability to competitively inhibit miRNA, and act as molecular “sponge”. ==Annotated Information== ===Name=== ''LINC01567''...")
- 02:43, 18 December 2018 (diff | hist) . . (-226) . . FZD10-AS1 (→Labs working on this lncRNA)
- 02:41, 18 December 2018 (diff | hist) . . (+4,942) . . N FZD10-AS1 (Created page with "''FZD10-AS1'' is studied along with long non-coding RNAs that have a potential role in neuronal regeneration after injury. However, it's role in neuron regeneration could not...")
- 08:02, 17 December 2018 (diff | hist) . . (+42) . . LINC02595
- 07:59, 17 December 2018 (diff | hist) . . (+2,637) . . N LINC02595 (Created page with "''LINC02595'' is involved in distant metastasis and dramatically associated with poor prognosis in patients with colorectal cancer (CRC). ==Annotated Information== ===Name===...")
- 07:23, 17 December 2018 (diff | hist) . . (+6,059) . . N LINC00514 (Created page with "''LINC00514'' is a top candidate implicated in the development of neuroendocrine prostate cancer (NEPC) and is also a strong candidate as predictive biomarker for metastatic d...")
- 06:44, 17 December 2018 (diff | hist) . . (0) . . LINC01561 (→Annotated Information)
- 06:43, 17 December 2018 (diff | hist) . . (+1) . . LINC01561 (→Annotated Information)
- 06:42, 17 December 2018 (diff | hist) . . (+4,667) . . N LINC01561 (Created page with "''lINC01561'' inhibition suppresses the breast cancer (BC) cells proliferation and promotes the apoptosis. ==Annotated Information== ===Name=== ''LINC01561'': long intergen...")
- 04:53, 17 December 2018 (diff | hist) . . (+228) . . TSPOAP1-AS1 (→References)
- 04:51, 17 December 2018 (diff | hist) . . (+208) . . LINC00174 (→References)
- 03:38, 17 December 2018 (diff | hist) . . (+1) . . LINC00174 (→Diseases)
- 03:37, 17 December 2018 (diff | hist) . . (+6,795) . . N LINC00174 (Created page with "Overexpression of ''LINC00174'' in colorectal cancer (CRC) tissues and cells correlates with poor prognosis and might be critical to CRC progression. ==Annotated Information...")
- 03:09, 17 December 2018 (diff | hist) . . (-273) . . TSPOAP1-AS1
- 03:07, 17 December 2018 (diff | hist) . . (+4,424) . . N TSPOAP1-AS1 (Created page with "''TSPOAP1-AS1'' is a lncRNA that may potentially serve as a novel candidate biomarker for the identification of breast cancer (BC) patients at high risk for tumor recurrence....")
- 07:58, 14 December 2018 (diff | hist) . . (+268) . . SH3PXD2A-AS1
- 06:51, 14 December 2018 (diff | hist) . . (+7) . . SH3PXD2A-AS1 (→Annotated Information)
- 05:31, 14 December 2018 (diff | hist) . . (+10) . . SSTR5-AS1 (→References)
- 05:30, 14 December 2018 (diff | hist) . . (+6,349) . . N SSTR5-AS1 (Created page with "''SSTR5-AS1'' is a top candidate implicated in the development of neuroendocrine prostate cancer (NEPC). This lncRNA robustly distinguishes NEPC from prostate adenocarcinoma (...")
- 02:58, 14 December 2018 (diff | hist) . . (+59) . . SH3PXD2A-AS1
- 02:49, 14 December 2018 (diff | hist) . . (+1) . . SH3PXD2A-AS1
- 02:48, 14 December 2018 (diff | hist) . . (+4,372) . . N SH3PXD2A-AS1 (Dysregulation of "SH3PXD2A-AS1'' is correlated with clinicopathological factors in colorectal cancer (CRC) patients.)
- 03:15, 12 December 2018 (diff | hist) . . (-2) . . HPYR1 (→Expression)
- 03:14, 12 December 2018 (diff | hist) . . (+6) . . HPYR1 (→Annotated Information)
- 03:13, 12 December 2018 (diff | hist) . . (-1) . . LINC00958 (→Expression)
- 03:12, 12 December 2018 (diff | hist) . . (+1) . . LINC00958 (→Function)
- 03:11, 12 December 2018 (diff | hist) . . (+1) . . LINC00958 (→Regulation)
- 03:09, 12 December 2018 (diff | hist) . . (-7) . . LINC00958 (→Diseases)
- 03:08, 12 December 2018 (diff | hist) . . (-2) . . LINC00958 (→Function)
- 03:06, 12 December 2018 (diff | hist) . . (+1) . . LINC00958 (→Name)
- 03:06, 12 December 2018 (diff | hist) . . (+2) . . LINC00958 (→Name)
- 03:04, 12 December 2018 (diff | hist) . . (+5,434) . . N LINC00958 (Long intergenic noncoding RNA 00958 (LINC00958) has an oncogenic role in the tumorigenesis of glioma and bladder cancer.)
- 07:51, 11 December 2018 (diff | hist) . . (+2,632) . . N HPYR1 (Created page with "''HPYR1'', Helicobacter pylori responsive 1, a novel gene confirmed in vivo in patients with H. pylori infection presents a case of pathogen induced changes in host gene expre...")